- Home
- NOTE vs AEON Comparison
NOTE vs AEON Comparison
Compare NOTE & AEON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NOTE | AEON |
|---|---|---|
| Founded | 2013 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.7M | 25.2M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | NOTE | AEON |
|---|---|---|
| Price | $1.22 | $1.05 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 1 |
| Target Price | ★ $29.25 | $7.20 |
| AVG Volume (30 Days) | ★ 261.7K | 236.3K |
| Earning Date | 03-12-2026 | 03-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $102,673,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $0.60 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.00 | $0.38 |
| 52 Week High | $24.36 | $10.01 |
Technical Indicators
Market Signals| Indicator | NOTE | AEON |
|---|---|---|
| Relative Strength Index (RSI) | 38.59 | 42.53 |
| Support Level | $1.17 | $1.01 |
| Resistance Level | $1.29 | $1.13 |
| Average True Range (ATR) | 0.12 | 0.08 |
| MACD | 0.00 | -0.02 |
| Stochastic Oscillator | 33.08 | 5.77 |
Price Performance
Historical ComparisonAbout NOTE FiscalNote Holdings Inc.
FiscalNote Holdings Inc is a provider of world-wide policy and market intelligence solutions. Leveraging AI and analytics, it delivers actionable legal and policy insights for businesses, government institutions, and nonprofits. Its suite of products includes FiscalNote Core, CQ Federal, and EU Issue Tracker, facilitating effective policy management and risk mitigation. With its analysis from FrontierView, Oxford Analytica, and Dragonfly Eye, it offers geopolitical and market intelligence services. Operating as one segment, it generates revenue by integrating policy intelligence into daily operations. Geographically the company generates the majority of its revenue from North America, Europe, Australia, and Asia, with the majority generated from North America.
About AEON AEON Biopharma Inc.
AEON Biopharma Inc is a clinical stage biopharmaceutical company focused on developing of its proprietary botulinum toxin complex ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, with an initial focus on the neurosciences market.